QPPV.COM KNOWLEDGE ASSESSMENT

EU Pharmacovigilance Compliance Monitoring: Detecting Failures Before Inspection

Test your understanding of the concepts covered by EU Pharmacovigilance Compliance Monitoring: Detecting Failures Before Inspection.

Question 1 of 10Pass mark: 80%

Question 1 of 10 What is the most appropriate progression after a deteriorating monitoring result is identified?
Question 2 of 10 Why might stratification be appropriate when monitoring ICSR timeliness?
Question 3 of 10 Which distinction between monitoring, audit and inspection is most accurate?
Question 4 of 10 After a major safety-database implementation, historical timeliness appears to improve sharply. What should the organisation verify before concluding that performance improved?
Question 5 of 10 A threshold is exceeded, but the monitoring procedure does not specify who reviews the result or what action follows. What weakness does this demonstrate?
Question 6 of 10 A metric remains below its formal threshold for four consecutive quarters but worsens each quarter. What is the best response?
Question 7 of 10 Which evidence chain would most persuasively demonstrate effective monitoring during an inspection?
Question 8 of 10 A company has completed a successful audit of its ICSR process. What is the most appropriate conclusion regarding ongoing monitoring?
Question 9 of 10 What is the most appropriate response when monitoring reveals a previously unanticipated risk pattern?
Question 10 of 10 Why is independent reconstruction of a historical monitoring result a valuable inspection-readiness test?

Select an answer to continue.

QPPV.com